Taking Stock
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.First-time dealings in two newcomers, due today, have been postponed until Friday for contrasting reasons. Oxford Biomedica lost two of its four underwriters at the last moment and cut its flotation to 10 per cent of its capital from 22 per cent. It is now raising pounds 5m against ambitions of pounds 11m.
Yeoman, a hi-tech group, delayed because of a late rush of private investors. Stockbroker Bell Lawrie White sought the postponement so it could accommodate the late comers.
Deltron Electronics held at 150p. It has signed a contract with Mitsubishi Electric of Japan for filter solutions which is worth up to pounds 3m a year. When it floated in September Deltron forecast profits of pounds 2.59m on pounds 25m turnover. Results are due in January.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments